• FirefoxInstall the new Firefox »
  •  Dow Down 0.57% Nasdaq Down 0.80%

    Incyte Corporation (INCY)

    -NasdaqGS
    88.56 Down 3.10(3.38%) 12:46PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:91.66
    Open:92.30
    Bid:88.78 x 100
    Ask:88.91 x 200
    1y Target Est:91.75
    Beta:0.16
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:87.76 - 92.48
    52wk Range:40.30 - 99.00
    Volume:585,679
    Avg Vol (3m):1,211,090
    Market Cap:15.21B
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYDown 3.38%15.21B
    AMGNDown 2.20%118.64B
    CELGDown 1.27%91.12B
    RHHBYUp 0.52%N/A

    Key Statistics

    Forward P/E (1 yr):88.91
    P/S (ttm):30.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.25
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-4.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback